Critical Review in Designing Plant-Based Anticancer Nanoparticles against Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC), accounting for 85% of liver cancer cases, continues to be the third leading cause of cancer-related deaths worldwide. Although various forms of chemotherapy and immunotherapy have been investigated in clinics, patients continue to suffer from high toxicity and undesir...

Descripción completa

Detalles Bibliográficos
Autores principales: Basu, Aalok, Namporn, Thanaphon, Ruenraroengsak, Pakatip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302838/
https://www.ncbi.nlm.nih.gov/pubmed/37376061
http://dx.doi.org/10.3390/pharmaceutics15061611

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10302838/
https://www.ncbi.nlm.nih.gov/pubmed/37376061
http://dx.doi.org/10.3390/pharmaceutics15061611

Ejemplares similares